The tumours of control and pHIFU + ICI-treated subjects showed that 2 ± 1% and 3 ± 1% of their live cells were CD3+CD4+FoxP3+, respectively, and 7 ± 4% and 10 ± 4% were CD11b+Ly6G+, respectively (figure 4f). The gene discussed is CD4; the disease is neoplasm.